Compare BORR & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BORR | HTFL |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | Bermuda | United States |
| Employees | N/A | 843 |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2017 | N/A |
| Metric | BORR | HTFL |
|---|---|---|
| Price | $3.88 | $25.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.25 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 4.0M | 1.4M |
| Earning Date | 05-20-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.80 | $27.66 |
| Revenue Next Year | $21.67 | $23.55 |
| P/E Ratio | $20.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.86 | $20.13 |
| 52 Week High | $6.66 | $41.22 |
| Indicator | BORR | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 31.96 | 42.86 |
| Support Level | $3.85 | $24.77 |
| Resistance Level | $4.61 | $32.69 |
| Average True Range (ATR) | 0.17 | 1.60 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 0.69 | 34.15 |
Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.